A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients

• Status: Completed
• Trial end date: 2016-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is for investigation and collection of Aricept safety information with a dose increase on Alzheimer's disease patients.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eisai Korea Inc.
• Treatments: Donepezil

Criteria

Inclusion Criteria

1. Patients who admitted the reading and using of his/her biographical and medical data by word

2. Patients who maintained Aricept dosage for at least 3 months before involved in the study

Exclusion Criteria

1. Hypersensitivity to the active substance or to any of the excipients

2. Breast feeding

3. Pregnancy